Sun Pharma expands tie-up with Cassiopea for acne cream to six countriesAs per the tie-up, the company will receive from Cassiopea the exclusive right to develop and commercialise WINLEVI in Japan, Australia, Ne...
Sun Pharma gets exclusive right to commercialise Winlevi acne cream in US, CanadaSun Pharma, North America CEO Abhay Gandhi said the expiration of the applicable waiting period under the US Hart-Scott-Rodino Antitrust Im...
Sun Pharma signs in-licensing deal to sell skincare drug in USAcne, being the most prevalent skin condition in the US, affects up to 50 million Americans annually. The last FDA approval of an acne drug...